BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2015
View Archived Issues
Medimmune begins phase I study of MEDI-1873 in solid tumors
Read More
BioAtla enters into strategic license and option agreement with Pfizer
Read More
Novel optimized human FVIII vector SPK-8005 demonstrates therapeutic utility in hemophilia
Read More
Takeda and Cour form celiac disease immunomodulator collaboration
Read More
Novartis starts phase III trial of indacaterol/glycopyrronium/mometasone in asthma
Read More
FACIT gains rights to WDR5 inhibitors for mixed lineage leukemia
Read More
First patient dosed in phase I/II study of NKTR-214
Read More
DBV initiates pivotal study of Viaskin Peanut in children
Read More
Biocept and Baylor College of Medicine to develop liquid biopsy test for estrogen receptor mutations
Read More
Lilly starts phase I trial of MCI candidate LY-2599666
Read More
Roche divulges TAAR1 ligands
Read More
Novartis initiates first-in-human trial of LNA-043
Read More
Vaxart tests influenza vaccine VXA-BYW.10 in healthy adults
Read More
Morphotek reports phase I data from MORAb-022-001 trial
Read More
Fluorescent tumor imaging achieved with BLZ-100 in phase I glioma trial
Read More
FDA advisory committee recommends approval of reslizumab
Read More
Gates Foundation funds research for a tapeworm vaccine
Read More
Bayer Schering Pharma reports MNK1 inhibitors
Read More
Wyss Institute to develop combined diagnostic and epinephrine injector device for anaphylaxis
Read More
Biocad's biosimilar bevacizumab approved in Russia
Read More
FDA decides to review Anika's Cingal as drug rather than device
Read More
Cancer Research Technology and AstraZeneca disclose glutaminase inhibitors
Read More
Fuji Chemical Industry develops carotenoid derivatives
Read More
Epizyme discovers first orally bioavailable SMYD3 inhibitor EPZ-031686
Read More
First-in-class CDK7 inhibitor SY-351 demonstrates efficacy in AML
Read More
Several collaborations announced in cancer immunotherapy and other related areas
Read More
Achillion's oral, small-molecule reversible factor D inhibitors for PNH and aHUS
Read More
ARMGO's ARM-210 receives FDA orphan drug and rare pediatric disease designation for DMD
Read More
FDA grants fast track to NuSirt's NS-0200 for NAFLD and NASH
Read More
TEI-SARM2 shows promise for the treatment of muscle wasting diseases
Read More